
    
      This is a multicenter, observational/non-interventional, cross-sectional study to describe
      the genetic diversity of and to identify the natural polymorphisms in HCV NS3/4a protease and
      NS5A protein of hepatitis C virus in Brazilian participants with chronic HCV infection.
      Brazilian participants with Genotype 1 HCV infection treatment naive participants or
      previously failed to double therapy (Peg-interferon-Î± and Ribavirin) will be included in the
      trial and will constitute the trial population.
    
  